Pages that link to "Q43836865"
Jump to navigation
Jump to search
The following pages link to Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets (Q43836865):
Displaying 15 items.
- A Comparative Overview of Prescription Omega-3 Fatty Acid Products (Q28972330) (← links)
- The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective (Q34513438) (← links)
- Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial (Q35903590) (← links)
- Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy (Q36836277) (← links)
- Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles (Q37146195) (← links)
- Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis. (Q40103769) (← links)
- Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic S (Q40764452) (← links)
- Triglyceride to high-density lipoprotein cholesterol ratio and carotid intima-medial thickness in Chinese adolescents with newly diagnosed type 2 diabetes mellitus (Q41591254) (← links)
- The cardiovascular risk reduction benefits of a low-carbohydrate diet outweigh the potential increase in LDL-cholesterol. (Q47593187) (← links)
- Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease. (Q54448960) (← links)
- Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. (Q54996163) (← links)
- Development of novel aptamers for low-density lipoprotein particle quantification (Q57281846) (← links)
- Precipitated sdLDL: An easy method to estimate LDL particle size (Q90553274) (← links)
- Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies (Q92248841) (← links)
- Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects (Q95576936) (← links)